ISB News

Arab Spring for Biology? Choose Open Access

This weekend, Burak Kutlu, one of our research scientists in the Hood Lab, is attending the Sage Bionetworks Commons Congress in San Francisco. The Congress will focus on "Building Better Models of Disease Together: Moving beyond the current medical information system and its rewards." He was selected as an outstanding Young Investigator. Here's his statement on why open access is important:

"The economics performing open science is not well defined. One of the reasons that we are failing to make major advancements in drug discovery is because most of the data sit behind walls until researchers decide to publish it. A pessimistic worldview dictates that the current failing system of new drug discovery will continue and there is no hope to change that. I am sure that a majority of the people living under dictatorship in Arab countries felt the same way, until some small group of people took leadership and finally managed to ignite a revolution that toppled the whole regimes. I would like to be part of the revolution to make open access mainstream and I look forward to the Sage Congress to network with people with the same agenda." – Burak Kutlu

Kutlu – whose work involves identifying gene regulatory networks involved in glioblastoma initiation and progression – will report on his experience at the Congress upon his return. Stay tuned.

Recent Articles

  • Dr. Sean Gibbons Promoted to Associate Professor

    Dr. Sean Gibbons – an expert in microbial ecology and evolution, computational systems biology, the human gut microbiome and its impacts on health, and head of ISB’s Gibbons Lab – has been promoted to Associate Professor. “Sean’s achievements since joining ISB in 2018 as a Washington Research Foundation Distinguished Investigator have been spectacular,” ISB President Dr. Jim Heath said. “With his focus on the microbiome, he brought a whole new…

  • AmeriCorps Member Sara Calder Joins ISB as Systems Health and STEM Coordinator

    Sara Calder recently joined ISB as Systems Health and STEM Coordinator, and is our second-ever AmeriCorps member. In this Q&A, Calder shares her education journey, her future plans, and much more.

  • In First-of-Its-Kind Trial, Scientists Use CRISPR to Treat Cancer

    Scientists for the first time have used CRISPR to substitute a gene to treat patients with cancer. The remarkable findings were published in the journal Nature and presented at the Society for Immunotherapy of Cancer (SITC) 2022.